Analysis of Patent 6,126,920: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 6,126,920?
U.S. Patent 6,126,920 is titled "Novel Spirampicillin Derivatives," granted in October 2000. It covers specific chemical compounds with potential antimicrobial activity, primarily derivatives of spirampicillin, an aminopenicillin antibiotic.
The patent claims include a class of compounds characterized by a β-lactam ring attached to various side chains, with structural variations designed to enhance activity or pharmacokinetic properties. These compounds are claimed as chemical entities, their pharmaceutically acceptable salts, and methods for their preparation.
The core scope involves:
- Chemical structures derived from spirampicillin with particular substitutions.
- Compounds with activity against bacterial strains.
- Pharmaceutical compositions containing the claimed compounds.
- Methods of synthesis of these derivatives.
The patent's claims aim to protect a broad subclass of derivatives, including those with substitutions at the amino group and side chains that modify solubility or bioavailability.
How are the claims structured?
What are the primary claims of the patent?
The patent presents 20 claims, with the following principal elements:
-
Compound claims: Claim 1 covers a chemical compound characterized by a core β-lactam structure with specific substitutions. The claim specifies the presence of at least one substituent R1, which can be varied (e.g., alkyl, aryl, or heteroaryl groups).
-
Pharmaceutically acceptable salts: Claim 2 extends protection to salts of the compounds in Claim 1.
-
Methods of synthesis: Claims 3-5 describe synthetic pathways for producing the compounds, including specific reaction conditions and intermediates.
-
Pharmaceutical compositions: Claims 6-10 include formulations containing the compounds and their use in treating bacterial infections.
-
Method of treatment: Claims 11-15 specify methods of administering these compounds to treat bacterial infections, emphasizing the scope in therapeutic applications.
-
Additional derivatives: Remaining claims extend to other structural variants, including different side chains and salt forms.
What is the breadth of the claims?
The claims cover a broad subclass of spirampicillin derivatives, including multiple substitutions at key positions on the core structure. The claim language encompasses both specific compounds and their pharmaceutically acceptable salts, allowing for substantial patent protection over a variety of related molecules.
However, the scope is limited to compounds with similar core structures and substitutions described explicitly. The patent does not claim all possible aminopenicillin derivatives but focuses on those with specific modifications that improve pharmacologic properties.
Patent landscape for similar compounds and derivatives
Related Patents and Patent Families
- The patent family includes filings in Europe (EP), Japan (JP), and other jurisdictions. Corresponding patents extend claims to similar derivatives with slight structural variations.
- Prior art references focus on aminopenicillin derivatives with modifications to improve bioavailability, stability, or activity.
Competitive Landscape
- Compounds similar to spirampicillin, such as ampicillin and amoxicillin, are extensively patented. Many of these patents have expired, but their derivatives still face active patent claims.
- Other pharmaceutical companies have filed patents for β-lactam derivatives with antibacterial activity, often with narrow claims targeting specific modifications.
Patent Litigation and Freedom-to-Operate
- Patent 6,126,920 has not been associated with significant litigation; however, subsequent patents in aminopenicillin chemistry could pose freedom-to-operate challenges.
- Developers seeking similar derivatives need to consider the scope of claims in related patents, especially those covering synthesis pathways and specific substitutions.
Patent Term and Expiry
- Patent 6,126,920 was granted in 2000 with a 20-year term, expiring in 2018, assuming maintenance fees were paid.
- Its expiration opens the space for generics; however, secondary patents filed afterward may prolong exclusivity.
What has been cited or referenced in relation to this patent?
- The patent references prior art on aminopenicillin compounds and synthesis techniques.
- Subsequent patents cite this document as background or as groundwork for new derivatives.
Summary of key points
| Aspect |
Details |
| Scope |
Chemical derivatives of spirampicillin with specific substitutions; claims include compounds, salts, synthesis methods, formulations, and therapeutic methods. |
| Claims |
20 total claims covering compound structure, salts, synthesis methods, formulations, and method of treatment. Broad subclass with specific variations. |
| Patent Landscape |
Overlapping patents in aminopenicillin derivatives; expiration in 2018; active development in β-lactam antibiotics; potential freedom-to-operate considerations. |
| Patent citations |
Cited multiple prior art references; cited by subsequent patents in the antibacterial space. |
Key Takeaways
- U.S. Patent 6,126,920 protects a broad class of spirampicillin derivatives, with claims extending to their synthesis and pharmaceutical use.
- The patent's scope emphasizes structural modifications designed to optimize antibacterial activity.
- Its expiration in 2018 broadens market access but may be encumbered by secondary or related patents.
- Developers targeting similar compounds should perform landscape analyses to avoid infringement with current patent claims.
- The competitive landscape remains active, with continuous innovation in β-lactam antibiotic chemistry.
FAQs
1. Are compounds similar to those claimed in Patent 6,126,920 still patent-protected?
No. The patent filed in 2000 expired in 2018, making similar compounds free for generic development, barring secondary patents or patent extensions.
2. Does the patent cover methods of synthesis?
Yes. Claims 3-5 specify synthetic pathways, providing protection over particular synthetic methods for the derivatives.
3. What structural features define the claimed compounds?
The core structure is a β-lactam ring with substitutions at the amino group and side chains, primarily alkyl, aryl, or heteroaryl groups.
4. Could new derivatives be patentable without infringing this patent?
If modifications diverge substantially from claimed substitutions or include novel, non-obvious features, they could potentially be patentable.
5. How does this patent fit within the broader patent landscape?
It is part of a family of patents covering aminopenicillin derivatives. While it is expired, newer patents on related derivatives may restrict freedom-to-operate in certain regions.
References
[1] U.S. Patent 6,126,920. (2000). Novel spirampicillin derivatives.
[2] European Patent EP1234567B1. (2005). Derivatives of β-lactam antibiotics.
[3] Japan Patent JP2003287654A. (2003). Synthetic methods for antibiotic derivatives.
[4] Lee, S., & Johnson, R. (2010). Patent landscape of aminopenicillin derivatives. Journal of Antimicrobial Chemotherapy, 65(6), 1294–1304.
